Skip to main content

AI news

Oracle and AstraZeneca agree to explore AI-assisted clinical research

Oracle and AstraZeneca announced a non-binding agreement to explore trial recruitment, real-world evidence and clinical workflow use cases. They plan shared governance and outcome measures, but have not announced a deployed integration, clinical results or a binding commercial rollout.

Oracle

Oracle–AstraZeneca exploratory AI agreement

Business & Adoption

Published (date only)

Updated

1 source

Primary source · Oracle · October 20, 2026

Opens Oracle in a new tab. Read it there before you rely on the summary above.

Read the original

Free, email only

Unlock the full brief free.

  • What to check before you trust this story, written down
  • Each verified source, with why it matters and who published it
  • A note whenever a source has been withdrawn
  • Thirty days of stories to browse, not seven
Continue with Google and subscribeContinue with Apple and subscribe

Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.

This is not an account: there is no password, and the unlock is a cookie in this browser. You also join Work Worth Doing, Demetri Panici's newsletter, every week: what I built and what changed in AI. We'll email you a link to confirm, and you can unsubscribe in one click. The same signup unlocks every free tool on the site. How your email is handled.

Already subscribed? Enter the same email to unlock this browser. You won't be signed up twice.